Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antibiotic Selection00:57

Antibiotic Selection

59.9K
Overview
59.9K
Range00:59

Range

14.2K
The range is one of the measures of variation. It can be defined as the difference between a dataset's highest and lowest values. For example, in the study of seven 16-ounce soda cans, the filled volume of soda was measured, thus producing the following amount (in ounces) of soda:
15.9; 16.1; 15.2; 14.8; 15.8; 15.9; 16.0; 15.5
Measurements of the amount of soda in a 16-ounce can vary since different subjects record these measurements or since the exact amount - 16 ounces of liquid, was not...
14.2K
¹H NMR: Long-Range Coupling01:27

¹H NMR: Long-Range Coupling

2.7K
The coupling interactions of nuclei across four or more bonds are usually weak, with J values less than 1 Hz. While these are usually not observed in spectra, the presence of multiple bonds along the coupling pathway can result in observable long-range coupling.
In alkenes, spin information is communicated via σ–π overlap, as seen in allylic (four-bond) and homoallylic (five-bond) couplings. These coupling interactions are stronger when the σ bond is parallel to the alkene...
2.7K
Gene Therapy00:59

Gene Therapy

27.6K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.6K
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

1.5K
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.5K
Variation: Normal Distribution, Range, and Standard Deviation02:32

Variation: Normal Distribution, Range, and Standard Deviation

28.2K
In the field of psychology, there are several ways to organize measurements of a trait, feature, or characteristic (i.e., variables). Qualitative data, such as ethnicity, can be tabulated into a frequency count to provide information about the proportion, as well as the variety of groups in a sample or population. On the other hand, researchers can perform a wider set of calculations on quantitative data. The mean, mode, and median, for instance, are central tendency measures to identify a...
28.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Design of Refractive Index Sensors Based on Valley Photonic Crystal Mach-Zehnder Interferometer.

Sensors (Basel, Switzerland)·2025
Same author

Field Prevalence and Pathological Features of <i>Edwardsiella tarda</i> Infection in Farmed American Bullfrogs (<i>Aquarana catesbeiana</i>).

Animals : an open access journal from MDPI·2025
Same author

Accurate Nonendoscopic Detection of Early Esophageal Squamous Malignant Lesions Using Sponge-Based Methylated DNA Biomarkers.

The American journal of gastroenterology·2025
Same author

Synthetic nano-kirigami with high deformability for reconfigurable information displays.

Nature communications·2025
Same author

Animal study of adhesiolysis via transumbilical endoscopic surgery with gastric endoscopy: an exploration.

BMC gastroenterology·2025
Same author

Sonoelectric Nanonet-Activated Extracellular Electron Transfer for Wireless Non-Genetic Stimulation of Pancreatic β Cells.

Angewandte Chemie (International ed. in English)·2025

Related Experiment Video

Updated: Feb 2, 2026

Phage Therapy Application to Counteract Pseudomonas aeruginosa Infection in Cystic Fibrosis Zebrafish Embryos
11:20

Phage Therapy Application to Counteract Pseudomonas aeruginosa Infection in Cystic Fibrosis Zebrafish Embryos

Published on: May 12, 2020

7.0K

Antibiotic Therapy Using Phage Depolymerases: Robustness Across a Range of Conditions.

Han Lin1, Matthew L Paff2, Ian J Molineux3,4,5

  • 1Department of Integrative Biology, University of Texas, Austin, TX 78712, USA. hanl@austin.utexas.edu.

Viruses
|November 15, 2018
PubMed
Summary

Bacteriophage depolymerase therapies show promise against bacterial capsules, but efficacy depends on treatment timing and administration route. Immune-suppressed mice demonstrated robust therapeutic success, even with delayed treatment.

Keywords:
animal modelantibioticbacterial infectionbacterial resistancecapsule depolymerasephage therapy

More Related Videos

Precise Phage Mutagenesis with NgTET-Assisted CRISPR-Cas Systems
10:52

Precise Phage Mutagenesis with NgTET-Assisted CRISPR-Cas Systems

Published on: October 14, 2025

665
'Bioluminescent' Reporter Phage for the Detection of Category A Bacterial Pathogens
11:31

'Bioluminescent' Reporter Phage for the Detection of Category A Bacterial Pathogens

Published on: July 8, 2011

14.0K

Related Experiment Videos

Last Updated: Feb 2, 2026

Phage Therapy Application to Counteract Pseudomonas aeruginosa Infection in Cystic Fibrosis Zebrafish Embryos
11:20

Phage Therapy Application to Counteract Pseudomonas aeruginosa Infection in Cystic Fibrosis Zebrafish Embryos

Published on: May 12, 2020

7.0K
Precise Phage Mutagenesis with NgTET-Assisted CRISPR-Cas Systems
10:52

Precise Phage Mutagenesis with NgTET-Assisted CRISPR-Cas Systems

Published on: October 14, 2025

665
'Bioluminescent' Reporter Phage for the Detection of Category A Bacterial Pathogens
11:31

'Bioluminescent' Reporter Phage for the Detection of Category A Bacterial Pathogens

Published on: July 8, 2011

14.0K

Area of Science:

  • Microbiology
  • Bacteriology
  • Antimicrobial Therapy

Background:

  • Phage-derived depolymerases target bacterial capsules, showing therapeutic potential in preclinical infection models.
  • Variability in animal model protocols can limit the generalizability of depolymerase therapy findings.

Purpose of the Study:

  • To investigate the robustness and limitations of phage depolymerase therapies in a murine infection model.
  • To assess the impact of treatment delay, administration route, and host immune status on therapeutic efficacy.

Main Methods:

  • Evaluated K1, K5, and K30 capsule-degrading depolymerases in mice with varying treatment delays and administration routes (intramuscular vs. intraperitoneal).
  • Assessed depolymerase efficacy in immune-suppressed, leukopenic mice, including those infected with resistant bacterial strains.
  • Compared efficacy of phage versus depolymerase treatments under delayed administration conditions.

Main Results:

  • Treatment delay reduced efficacy, with K1 and K5 depolymerases retaining partial efficacy, while K30 did not.
  • Route of administration significantly impacted K1E depolymerase success; phage outperformed enzymes only with delayed K1 treatment.
  • K1 depolymerases were highly effective in immune-suppressed, leukopenic mice, even with delayed treatment and resistant bacteria (which were avirulent).

Conclusions:

  • Phage depolymerases are effective antibacterial agents in vivo, but their success is contingent on specific experimental conditions.
  • System-specific factors, including host immunity and bacterial resistance, critically influence depolymerase therapy outcomes.
  • Further research is needed to optimize depolymerase therapy protocols for clinical translation.